5vvf
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 5vvf is ON HOLD Authors: Scharf, L., Gristick, H.B., Bjorkman, P.J. Description: Crystal Structure of 354BG1 Fab [[Category: Unreleased Structures]...) |
|||
| (3 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal Structure of 354BG1 Fab== | |
| + | <StructureSection load='5vvf' size='340' side='right'caption='[[5vvf]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[5vvf]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5VVF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5VVF FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5vvf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5vvf OCA], [https://pdbe.org/5vvf PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5vvf RCSB], [https://www.ebi.ac.uk/pdbsum/5vvf PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5vvf ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | The HIV-1 envelope (Env) glycoprotein binds to host cell receptors to mediate membrane fusion. The prefusion Env trimer is stabilized by V1V2 loops that interact at the trimer apex. Broadly neutralizing antibodies (bNAbs) against V1V2 loops, exemplified by PG9, bind asymmetrically as a single Fab to the apex of the symmetric Env trimer using a protruding CDRH3 to penetrate the Env glycan shield. Here we characterized a distinct mode of V1V2 epitope recognition by the new bNAb BG1 in which two Fabs bind asymmetrically per Env trimer using a compact CDRH3. Comparisons between cryo-EM structures of Env trimer complexed with BG1 (6.2 A resolution) and PG9 (11.5 A resolution) revealed a new V1V2-targeting strategy by BG1. Analyses of the EM structures provided information relevant to vaccine design including molecular details for different modes of asymmetric recognition of Env trimer and a binding model for BG1 recognition of V1V2 involving glycan flexibility. | ||
| - | + | Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies.,Wang H, Gristick HB, Scharf L, West AP, Galimidi RP, Seaman MS, Freund NT, Nussenzweig MC, Bjorkman PJ Elife. 2017 May 26;6. pii: e27389. doi: 10.7554/eLife.27389. PMID:28548638<ref>PMID:28548638</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | [[Category: | + | </div> |
| - | [[Category: | + | <div class="pdbe-citations 5vvf" style="background-color:#fffaf0;"></div> |
| - | [[Category: Bjorkman | + | == References == |
| - | [[Category: Scharf | + | <references/> |
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Bjorkman PJ]] | ||
| + | [[Category: Gristick HB]] | ||
| + | [[Category: Scharf L]] | ||
Current revision
Crystal Structure of 354BG1 Fab
| |||||||||||
